+5.7%
CVS vs EPAM
-77.4%
+83.1%
-56.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | EPAM | Excess | Alpha |
|---|---|---|---|---|
| 1D | +3.1% | -3.9% | +7.0% | +3.2% |
| 7D | -7.1% | +13.4% | -20.5% | -7.6% |
| 30D | -4.0% | +47.1% | -51.1% | -5.3% |
| 3M | -12.2% | +71.2% | -83.4% | -13.9% |
| 6M | -2.2% | +48.9% | -51.1% | -3.7% |
| YTD | +8.9% | -22.2% | +31.1% | +9.5% |
| 1Y | +9.9% | -5.2% | +15.0% | +9.5% |
| 3Y | +32.1% | -34.9% | +67.0% | +32.3% |
| All | +5.7% | -77.4% | +83.1% | +7.8% |
Cumulative growth
Daily Returns
Daily percentage return beside EPAM.
Daily Out/Under-Performance
Portfolio return minus EPAM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EPAM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded EPAM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling